FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a nasal antimicrobial therapeutic agent containing active and auxiliary materials differing by the fact, that ciprofloxacin hydrochloride antibiotic is selected as active material, and as auxiliary materials are selected - propylene glycol, macrogol glyceryl hydroxystearate, benzalkonium hydrochloride, purified water, wherein the ingredients in the preparation are taken in certain proportions, wt%.
EFFECT: invention provides expansion of the range of nasal application antibacterial agents for treating rhinitis, rhinopharyngitis and sinusitis.
3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION IN FORM OF NALOXONE HYDROCHLORIDE-BASED NASAL SPRAY AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2572217C2 |
| ARTIFICIAL NASAL SECRET | 2022 |
|
RU2800117C1 |
| PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION CONTAINING CORTICOSTEROID AND QUINOLONE OR FUSIDIC ACID | 2012 |
|
RU2614716C2 |
| OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
| COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
| CREAM FOR MEDICINAL PURPOSES, MADE WITH APPLICATION OF FRAMYCETIN SULFATE AND CHITOSAN | 2010 |
|
RU2536266C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF UPPER RESPIRATORY TRACT DISEASES AND MEDICINAL PRODUCT BASED THEREON | 2019 |
|
RU2748548C1 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| PHARMACEUTICAL COMPOSITION OF LOCAL APPLICATION FOR INFECTIOUS INFLAMMATORY DISEASES TREATMENT, AND METHOD FOR ITS PRODUCTION AND APPLICATION | 2016 |
|
RU2627423C1 |
| COMBINED ANTIALLERGIC DRUG FOR NASAL APPLICATION | 2018 |
|
RU2744097C2 |
